Skip to main content
Premium Trial:

Request an Annual Quote

Vicki Sato, Yung Nien Chang, Gregory Feulner, and John Woolford

Premium

Alnylam Pharmaceuticals said this week that Vicki Sato has been elected to the company's board of directors.

Sato was formerly president of Vertex Pharmaceuticals. Before this, she served as the company's CSO and chief of the scientific advisory board. Prior to joining Vertex, she held various positions at Biogen.

She holds a BS, MS, and PhD from Harvard University.


Lentigen said last week that it has named three new members of its management team (see full story, this issue).

Joining the company is Yung Nien Chang, formerly vice president of research and development at VirxSys, as vice president of vector development.

Before working at VirxSys, Chang was a senior scientist and group leader at Genetic Therapy, which later merged with Novartis. He holds a PhD in biology from the University of North Texas, an MS from the National Defense Medial Center in Taiwan, and a BS from Tunghai University.

Lentigen also said that it has tapped Gregory Feulner to be the company's vice president of business development. Prior to joining Lentigen, Feulner held similar positions at Galileo Genomics and Gene Logic. He holds a BS in biology and chemistry from the University of Delaware, a PhD in biochemistry from Pennsylvania State University, and a JD from Syracuse College of Law.

Lentigen also said that John Woolford has been named the company's director of business planning. Most recently, he was a vice president and equity analyst at Legg Mason Wood Walker, where he followed the biotechnology and life science sectors. He has also held positions in the contract manufacturing division of MedImmune. He holds an MBA and a BS in microbiology from the University of Maryland.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.